NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

Indian pharmaceutical companies head into 2026 with a clearer tilt towards specialty medicines as sustained pricing pressure continues to weigh on returns from traditional generics. With export ...

U.S. President Donald Trump is reflected in a television screen while speaking with members of the media on board Air Force One en route to Palm Beach, Florida, U.S., January 31, 2026. REUTERS/Nathan ...